Time, distance, shielding, and radioprotectants

Health Physics

Volumn 87, Issue 1, 2004, Pages 1-2

  Kasper, Ken ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GENISTEIN; HE 2100; PHOSPHONOL; RADIOPROTECTIVE AGENT; UNCLASSIFIED DRUG;

CELL PROLIFERATION; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOSTIMULATION; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; RADIOBIOLOGY; SHORT SURVEY; TERRORISM;

RADIATION INJURIES; RADIATION PROTECTION; RADIATION-PROTECTIVE AGENTS; SAFETY MANAGEMENT; TERRORISM;

EID: 2942657553     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-200407000-00001     Document Type: Short Survey

References (5)

1. Armed Forces Radiobiology Research Institute. Medical management of radiological casualties. Bethesda, MD: AFRRI; 2003.
2. Congressional Pharmaceutical Corporation. CPC announces genoprotective agent conferred delayed protection from radiation - Investigational drug being developed as countermeasure for nuclear threats. PR Newswire, 19 June 2003.
3. Hollis-Eden Pharmaceuticals. Press release titled Department of Defense Medical School and Hollis-Eden Form Collaboration to Develop Drug for Protection Against Radiation Damage. San Diego, CA: HEP; February 2002.
4. Kumar KS, Srinivasan V, Toles R, Jobe L, Seed TM. Nutritional approaches to radioprotection: vitamin E. Military Med 167 (Supplement):57-59; 2002.
5. Landauer MR, Srinivasan V, Seed TM. Genistein treatment protects mice from ionizing radiation injury. J Applied Toxicol 23(6)279-85; 2003.